Tirzepatide: FDA records on compounded and unapproved products

Has FDA taken action on compounded tirzepatide?

Yes. As of Nov 15, 2026, FDA has issued 111 warning letters to 109 companies whose text names tirzepatide, the latest dated Oct 30, 2026, and openFDA lists 28 recall reports naming it. FDA stated that tirzepatide and semaglutide do not currently appear on the 503B bulks list or on FDA’s drug shortage list (statement dated Apr 1, 2026).

As of Nov 15, 2026, FDA’s drug shortage data lists no tirzepatide products.

What FDA has stated, by date

FDA’s page does not date each paragraph; the date shown is the page’s “content current as of” date.

FDA drug shortage status

No tirzepatide entries in FDA’s drug shortage data as of Nov 15, 2026.

Shortage history, by date

FDA’s words or recordSource
Dec 15, 2022Listed“Tirzepatide injection products were first added to FDA’s drug shortage list on December 15, 2022.”FDA Declaratory Order, December 19, 2024: Resolution of Shortages of Tirzepatide Injection Products (Mounjaro and Zepbound)
April 2024Listed“The Zepbound pen products were approved by FDA in November 2023 (NDA 217806) and added to FDA’s drug shortage list in April 2024 due to high demand.”FDA Declaratory Order, December 19, 2024: Resolution of Shortages of Tirzepatide Injection Products (Mounjaro and Zepbound)
Oct 2, 2024Resolved“The U.S. Food and Drug Administration has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been resolved. Tirzepatide injection has been in shortage since 2022 due to increased demand.”FDA: FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
Oct 22, 2024Litigation“As part of litigation, the decision to remove tirzepatide from the FDA drug shortage list has been remanded to the agency for reevaluation.”FDA: FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
Dec 19, 2024Resolved“This order revokes and replaces FDA’s October 2, 2024 decision on the same subject. I. Determination FDA determines that the tirzepatide injection product shortage is resolved.”FDA Declaratory Order, December 19, 2024: Resolution of Shortages of Tirzepatide Injection Products (Mounjaro and Zepbound)
Feb 18, 2025503A grace period end“For state-licensed pharmacists or physicians compounding under section 503A of the FD&C Act, 60 calendar days from the date of this order, until February 18, 2025”FDA Declaratory Order, December 19, 2024: Resolution of Shortages of Tirzepatide Injection Products (Mounjaro and Zepbound)
Mar 5, 2025Litigation“On March 5, 2025, the district court denied the plaintiffs’ preliminary injunction motion in Outsourcing Facilities Association v. FDA, 4:24-cv-00953 (N.D. Tex.).”FDA: FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
Mar 19, 2025503B grace period end“For outsourcing facilities under section 503B of the FD&C Act, 90 calendar days from the date of this order, until March 19, 2025.”FDA Declaratory Order, December 19, 2024: Resolution of Shortages of Tirzepatide Injection Products (Mounjaro and Zepbound)
Apr 1, 2026Status statement“Tirzepatide and semaglutide do not currently appear on the 503B bulks list or on FDA’s drug shortage list.”FDA: FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize

All GLP-1 drugs on one timeline: shortage history.

FDA adverse event reports (FAERS) listing tirzepatide

openFDA’s copy of FDA’s adverse event database holds 181,257 reports that list tirzepatide, received from Jul 28, 2015 through Sep 30, 2026. 33,215 (18%) are marked serious by the reporter, including 1,052 that list death as an outcome. 189 reports name a compounded or combination tirzepatide product in the product fields. These are unverified reports and do not show that the drug caused any event.

FAERS reports are sent to FDA by drug makers, health professionals and the public. FDA does not verify them, a report does not show that the drug caused the event, and the same event can be reported more than once. Counts reflect how often events were reported, not how often they happen or how risky a drug is. Nothing here is medical advice. Report an error or add a company response.

Reports by year FDA received them

20151
20166
20177
20184
201928
202033
202138
20225,052
202320,806
202433,068
202562,369
202659,845

Reaction terms listed most often

Incorrect dose administered32,16017.7%
Nausea19,76010.9%
Injection site pain14,6228.1%
Diarrhoea11,3326.3%
Extra dose administered10,2885.7%
Off label use10,0425.5%
Vomiting9,4225.2%
Drug ineffective8,3014.6%
Constipation7,6304.2%
Fatigue5,7113.2%

A report can list several reaction terms. Terms such as “Off label use” or “Incorrect dose administered” describe how the drug was used, not a bodily reaction.

Reports naming a compounded or combination tirzepatide product

In openFDA’s public copy of FDA’s adverse event data, checked Nov 15, 2026, 189 reports of the 181,257 listing tirzepatide have product text that identifies a compounded or combination product: 188 list tirzepatide combined with a vitamin or amino acid such as cyanocobalamin (vitamin B12), and 1 use the word “compounded” or “compound” in the product name or dosage text. The public data has no compounded flag and no narrative, so this is a floor, not a full count, and the reports are unverified. More on the compounded tirzepatide reports page.

A report is counted as naming a compounded product only when one drug entry in it names the drug and that same entry either uses the word “compounded”, “compounding” or “compound” in its product name or dosage text, or lists the drug together with cyanocobalamin, methylcobalamin, pyridoxine, glycine, levocarnitine, carnitine, niacinamide or vitamin B12 or B6 in one product name, a combination no FDA-approved product of these drugs contains. openFDA’s public data has no field that marks a product as compounded and leaves out the report narrative, so this finds only reports whose product text shows it. FDA’s own counts for compounded semaglutide and tirzepatide, from its full internal data, are higher.

Report
Sep 30, 2026CYANOCOBALAMIN\NADIDE\TIRZEPATIDECombined with a vitamin or amino acidSuspectYesopenFDA 27328171
Sep 24, 2026CYANOCOBALAMIN\GLYCINE\TIRZEPATIDECombined with a vitamin or amino acidSuspectYesopenFDA 27310876
Sep 22, 2026CYANOCOBALAMIN\TIRZEPATIDECombined with a vitamin or amino acidSuspectYesopenFDA 27291966
Sep 22, 2026GLYCINE\TIRZEPATIDECombined with a vitamin or amino acidSuspectYesopenFDA 27297319
Sep 19, 2026PYRIDOXINE\TIRZEPATIDECombined with a vitamin or amino acidSuspectNoopenFDA 27286507
Sep 18, 2026GLP1 Tirzepatide/NiacinamideCombined with a vitamin or amino acidConcomitantYesopenFDA 27278464
Sep 17, 2026NIACINAMIDE\TIRZEPATIDECombined with a vitamin or amino acidSuspectNoopenFDA 27272866
Sep 14, 2026CYANOCOBALAMIN\TIRZEPATIDECombined with a vitamin or amino acidSuspectYesopenFDA 27254934
Sep 14, 2026GLYCINE\TIRZEPATIDECombined with a vitamin or amino acidSuspectNoopenFDA 27259804
Sep 11, 2026LEVOCARNITINE\TIRZEPATIDECombined with a vitamin or amino acidSuspectNoopenFDA 27243278
Sep 11, 2026CYANOCOBALAMIN\GLYCINE\TIRZEPATIDECombined with a vitamin or amino acidSuspectYesopenFDA 27248058
Sep 10, 2026GLYCINE\TIRZEPATIDECombined with a vitamin or amino acidSuspectNoopenFDA 27242594
Sep 8, 2026LEVOCARNITINE\TIRZEPATIDECombined with a vitamin or amino acidSuspectNoopenFDA 27231004
Sep 6, 2026LEVOCARNITINE\TIRZEPATIDECombined with a vitamin or amino acidSuspectNoopenFDA 27227103
Sep 5, 2026PYRIDOXINE\TIRZEPATIDECombined with a vitamin or amino acidSuspectNoopenFDA 27226022
Sep 3, 2026TIRZEPATIDEProduct text says compoundedSuspectYesopenFDA 27205951
Sep 3, 2026PYRIDOXINE\TIRZEPATIDECombined with a vitamin or amino acidSuspectYesopenFDA 27212705
Sep 2, 2026CYANOCOBALAMIN\TIRZEPATIDECombined with a vitamin or amino acidSuspectYesopenFDA 27208032
Sep 1, 2026PYRIDOXINE\TIRZEPATIDECombined with a vitamin or amino acidSuspectNoopenFDA 27197290
Sep 1, 2026CYANOCOBALAMIN\GLYCINE\TIRZEPATIDECombined with a vitamin or amino acidSuspectYesopenFDA 27202230
Aug 31, 2026GLYCINE\TIRZEPATIDECombined with a vitamin or amino acidSuspectNoopenFDA 27196091
Aug 27, 2026GLYCINE\TIRZEPATIDECombined with a vitamin or amino acidSuspectYesopenFDA 27183302
Aug 26, 2026GLYCINE\METHYLCOBALAMIN\TIRZEPATIDECombined with a vitamin or amino acidSuspectYesopenFDA 27174054
Aug 26, 2026METHYLCOBALAMIN\TIRZEPATIDECombined with a vitamin or amino acidSuspectNoopenFDA 27177831
Aug 24, 2026GLYCINE\TIRZEPATIDECombined with a vitamin or amino acidSuspectNoopenFDA 27167056

The 25 most recent are shown; all 189 are on the adverse event reports page.

Active ingredient (API) imports: FDA import alert and refusal records

FDA’s Import Alert 66-80 Green List (published Oct 9, 2026) has 9 entries naming tirzepatide, in China (8) and Canada (1); FDA redacts the firm names. FDA’s import refusal records list 201 refused shipment lines whose product code names tirzepatide, from Aug 30, 2023 to Oct 29, 2026, most often from Canada (39), United States (32) and United Kingdom (27); 21 carry an API or powder product code listed on the alert.

Import Alert 66-80 Green List entries naming tirzepatide

Product codes and drugs listed
2Redacted by FDACANADA61P[][]74 Tirzepatide (Anti-Diabetic)
5Redacted by FDACHINA61P[][]76 Liraglutide (Anti-Diabetic)
61P[][]72 Semaglutide (Anti-Diabetic)

61P[][]74 Tirzepatide (Anti-Diabetic)
6Redacted by FDACHINA61P[][]74 Tirzepatide (Anti-Diabetic)
7Redacted by FDACHINA61P[][]76 Liraglutide (Anti-Diabetic)
61P[][]72 Semaglutide (Anti-Diabetic)

61P[][]74 Tirzepatide (Anti-Diabetic)
8Redacted by FDACHINA61P[][]76 Liraglutide (Anti-Diabetic)
61P[][]72 Semaglutide (Anti-Diabetic)

61P[][]74 Tirzepatide (Anti-Diabetic)
10Redacted by FDACHINA61P[][]76 Liraglutide (Anti-Diabetic)
61P[][]72 Semaglutide (Anti-Diabetic)

61P[][]74 Tirzepatide (Anti-Diabetic)
11Redacted by FDACHINA61P[][]74 Tirzepatide (Anti-Diabetic)
61P[][]77 Orforglipron (Anti-Diabetic)
12Redacted by FDACHINA61P[][]72 Semaglutide (Anti-Diabetic)
61P[][]74 Tirzepatide (Anti-Diabetic)
13Redacted by FDACHINA61P[][]76 Liraglutide (Anti-Diabetic)
61P[][]72 Semaglutide (Anti-Diabetic)

61P[][]74 Tirzepatide (Anti-Diabetic)

Refused tirzepatide lines by country and form

Canada39
United States32
United Kingdom27
China21
India18
Italy12
Japan9
Netherlands7
France6
Turkey6
Bangladesh5
Hong Kong3
Vietnam3
Colombia2
Germany2
Lithuania2
Switzerland2
Australia1
Paraguay1
Philippines1
Portugal1
United States Outlying Islands1
Code not listed on Import Alert 66-80180
Active Pharm Ingred/Chems for Rx Compounding9
Sterile Powder6
NonSterile Powder5
Active Pharm Ingred/Chems for Further Manuf1

Most recent refused tirzepatide lines

Shipment ID
Oct 29, 2026Name not shownItaly61PCY74 TIRZEPATIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80SCS-5299095-7/10003/1
Oct 7, 2026SHANGHAI SHUNYI TRADE CO LTDChina61PIR74 TIRZEPATIDE (ANTI-DIABETIC)NonSterile PowderXXX-0763321-9/1/1
Oct 7, 2026XU LIHUA JINGFANG Trading Co. LTDChina61PIR74 TIRZEPATIDE (ANTI-DIABETIC)NonSterile PowderXXX-0763336-3/1/2
Sep 28, 2026Name not shownChina61PCR74 TIRZEPATIDE (ANTI-DIABETIC)NonSterile PowderXXX-0763136-5/1/1
Sep 25, 2026Name not shownUnited States61PDY74 TIRZEPATIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-801FX-2853870-1/10001/1
Sep 22, 2026MITSUBISHI TANABE PHARMA CORPORATION .Japan61PCP74 TIRZEPATIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-801FX-8179469-5/10002/1
Sep 14, 2026BIOAMINO LABSGermany61PCZ74 TIRZEPATIDE (ANTI-DIABETIC)Sterile PowderXXX-0761571-4/1/1
Sep 10, 2026ELI LILLY JAPANJapan61PCL74 TIRZEPATIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80AEK-9702092-7/10002/1
Sep 8, 2026Eli Lilly Italia SPAItaly61PCY74 TIRZEPATIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80AEK-9744427-5/10002/1
Sep 3, 2026Eli Lilly Japan K.K.Seishin LaboratoriesJapan61PCK74 TIRZEPATIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80AEK-0976985-1/10002/1A
Sep 3, 2026Eli Lilly Japan K.K.Seishin LaboratoriesJapan61PCK74 TIRZEPATIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80AEK-0976985-1/10002/1B
Sep 3, 2026Eli Lilly Japan K.K.Seishin LaboratoriesJapan61PCK74 TIRZEPATIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80AEK-0976985-1/10002/1C
Aug 31, 2026Eli Lillyand CompanyUnited States61PCY74 TIRZEPATIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80AEK-0896550-0/10001/1
Aug 19, 2026MITSUBISHI TANABE PHARMA CORPORATION .Japan61PCY74 TIRZEPATIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-801FX-8049552-6/10002/1
Aug 14, 2026Eli Lilly & CompanyUnited States61PCK74 TIRZEPATIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80AEK-0899186-0/10002/1
Jul 31, 2026Name not shownVietnam61PCY74 TIRZEPATIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80SCS-0349383-8/40002/2
Jul 27, 2026Eli Lilly Japan K.K.Seishin LaboratoriesJapan61PDL74 TIRZEPATIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80AEK-9601308-9/10002/1
Jul 27, 2026Eli Lilly Japan K.K.Seishin LaboratoriesJapan61PDL74 TIRZEPATIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80AEK-9601308-9/10002/2
Jul 24, 2026CHONGUHAN MEDICAL TECHNOLOGIESChina61PDA74 TIRZEPATIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80AEK-0834622-2/10002/1
Jul 22, 2026ELI LILLY AND COMPANY PVT LTDIndia61PCY74 TIRZEPATIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80AEK-0437132-3/10002/1

The 20 most recent of 201 are shown, with charges, on the GLP-1 import records page and in the CSV download.

All firms and countries: Firms on GLP-1 import records.

FDA NDC Directory listings

FDA’s NDC Directory files read Nov 15, 2026 carry 201 listings naming tirzepatide: NDA (54); BULK INGREDIENT (46); DRUG FOR FURTHER PROCESSING (42); OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (33); BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING (26). Outsourcing facility listings: Which outsourcing facilities list compounded semaglutide or tirzepatide with FDA? Every listing: GLP-1 listings in FDA’s NDC Directory. FDA says an NDC “does not in any way denote FDA approval of the product.”

Medicare and Medicaid spending on tirzepatide

Medicare Part D spent $6.34 billion on tirzepatide brands in 2024 (Mounjaro $6.34 billion, Zepbound $387,343), before manufacturer rebates, according to CMS. Pharmacies were reimbursed at least $3.32 billion for tirzepatide products paid through Medicaid nationwide in 2025, across at least 3,140,509 prescriptions, according to CMS’s State Drug Utilization Data. That is the total amount reimbursed, federal and state shares together, before the rebates manufacturers pay states. CMS suppressed 53 rows of 194, so these figures are floors.

Medicare Part D, by brand and year

MounjaroTirzepatideNo dataNo data$144,035,152$2,361,384,157$6,336,942,641
ZepboundTirzepatideNo dataNo dataNo dataNo data$387,343

Medicaid, nationwide, by year

2020No data
2021No data
2022at least $34,060,250
2023at least $439,944,750
2024at least $1,205,743,835
2025at least $3,323,545,465
2026 (Q1)at least $911,460,172

Figures are before manufacturer rebates, as CMS reports them. Every GLP-1 drug, CMS’s caveats and each state: Medicare and Medicaid spending on GLP-1 drugs.

FDA warning letters naming tirzepatide

Later letters FDA listsLetter
Oct 30, 2026RonanRx, Inc. dba RonanRxFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 18, 2026Empower Clinic Services, LLC dba Empower PharmacyCGMP/Finished Pharmaceuticals/Adulterated/Unapproved New DrugSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Aug 24, 2026TXP Innovations LLC dba Tex PeptidesUnapproved New Drugs/MisbrandedSemaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Aug 24, 2026Royal Peptides LLCUnapproved New Drugs/MisbrandedSemaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Aug 24, 2026Peptide Partners LLCUnapproved New Drugs/MisbrandedSemaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Maximus Health, Inc. dba MaximusFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Trinity HealthCare Supply, LLC dba altRxFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Glow Medispa, LLC dba Mint MedFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Ezra Holdco LLC dba EzraFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Public Health Solution LLC dba DrMedHealthFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026D&H Medical ServicesFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Amie Health, Inc. dba AmieFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Altru Telehealth, LLC dba Altru TelehealthFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Eden Health International Inc. dba EdenFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026NativeMed LLC dba NativeMedFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026FitRX, LLC dba AM RXFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Momentum Health 360 dba Momentum HealthFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, Tirzepatide, LiraglutideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Medica Weight LossFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Clover Meds LLC dba Clover MedsFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Nexlife Inc. dba NexlifeFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Joi and Blokes dba Joi + BlokesFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026VivioMD Group LLC dba VivioMDFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Nexus Health Solutions LLC dba Harper MedsFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Nova Vascular LLC dba NOVARXFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Ready MedFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026OrderlyMeds LLC dba OrderlyMedsFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026HydraMed IV LLC dba HydraMedFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026FITISHFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
May 1, 2026Harbin Jixianglong Biotech Co., Ltd.CGMP/API/Adulterated and Misbranded DrugsSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Apr 14, 2026New Life Pharma LLCCGMP/Adulterated and Unapproved New Drug/MisbrandedSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Apr 7, 2026ProRx LLCCompounding Pharmacy/Adulterated Drug ProductsSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Mar 31, 2026Prime SciencesUnapproved New Drugs Sold Over the InternetSemaglutide, Tirzepatide, Retatrutide, Cagrilintide, MazdutideNone listed by FDA as of Nov 15, 2026fda.gov
Mar 31, 2026Mile High Compounds LLCUnapproved New Drugs Sold Over the InternetSemaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Mar 31, 2026Lovega LLC dba Pink Pony PeptidesUnapproved New Drugs Sold Over the InternetTirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Mar 31, 2026Gram PeptidesUnapproved New Drugs Sold Over the InternetTirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Premium Health Management Inc. dba Premium HealthFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Bliv Wellness LLC dba BlivFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026BluefitMDFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Deluxe IV Aesthetics PLLC dba Deluxe IV and AestheticsFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Aspen Aesthetics dba Fifty 410False & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026FitRX, LLC dba FitRxFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Genesis Health International Inc. dba GenesisFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Lean Rx, Inc. dba SkinnyRxFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Kare Solutions, LLC dba ZappyFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, Tirzepatide, LiraglutideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Strut Health, LLC dba StrutFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Weightless Medical LLC dba WeightCareFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Viv Health, Inc. dba VIV RXFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026PharmaZeeFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Good Girl LLC dba GoodGirlRXFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Ivim Services LLC dba IvimFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Join JosieFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Kin MedsFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026MaxLife Technologies Inc. dba MaxlifeFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Better Health Labs, Inc. dba MeasuredFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026MEDVi, LLC dba MEDViFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Newman Clinic, PLLC dba Newman ClinicFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026NewSelf Limited dba NewSelfFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 202624HrDoc, Inc. dba 24HrDocFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Alan Health Technologies Inc. dba AlanFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Dripgym Mobile Parent, LLC dba Amp HealthFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Belle Health LLC dba BelleFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Zeuss LLC dba ZeussFalse & Misleading Claims/Misbranded (Telehealth)TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 9, 2026Thrive Health and Wellness, LLC dba Thrive Health SolutionsCompounding Pharmacy/Adulterated Drug ProductsTirzepatideClose-out letter, Aug 6, 2026fda.gov
Jan 20, 2026GenoGenix LLCCompounding Pharmacy/Adulterated Drug ProductsSemaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Jan 16, 2026Boothwyn Pharmacy, LLCCompounding Pharmacy/Adulterated Drug ProductsSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Dec 1, 2025Apothecary Pharma, LLCCompounding Pharmacy/Adulterated Drug ProductsSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Expert AestheticsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025GenLabMedsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Get.Fit.Medical, LLC dba Get.Fit.MedicalUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025FWD Care, Inc. dba FWDUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Lean Dreams LLC dba LeanDreamsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025ybycmedsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Vitals RXUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Tuyo Health, Inc. dba Tuyo HealthUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Lovely Meds, Inc. dba Lovely MedsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Lyfe RxUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025inspire.clinicUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Bioverse, Inc. dba BioverseUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025SimpleRxUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Elevate Your Wellness LLC, dba ElevatedUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025EvoLife WellnessUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Nuvo Life Health Inc. dba Nuvo Life HealthUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025directmeds.com, Inc. dba DirectMedsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025LumimedsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025GLP-1 SolutionUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025ASN-LABSUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025All American WellnessUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Intimate RoseUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Invigorate Med SpaUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Dr. Gater’s Weight Loss & WellnessUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Remedy MedsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025EA WORKS Limited Liability Company dba Trust LabsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Fancy Meds, LLC dba Fancy MedsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025CurexUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Healthon Inc. dba HealthonUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025SlendidUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Sprout Health Partners LLC dba Sprout HealthUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Master Pharmaceuticals GroupUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025TRYM Health, Inc. dba TRYM HealthUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Reset IV, LLC dba Reset IVUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025eDrugstoreUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Healthy MaleUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Apr 8, 2025Tailstorm Health Inc. dba Medivant HealthCompounding Pharmacy/Adulterated Drug ProductsSemaglutide, TirzepatideClose-out letter, Apr 14, 2026fda.gov
Mar 4, 2025ProRx, LLCCompounding Pharmacy/Adulterated Drug ProductsSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 26, 2025USApeptide.comUnapproved New Drugs/MisbrandedSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Dec 10, 2024Prime Vitality, Inc. dba Prime PeptidesUnapproved New Drugs/MisbrandedSemaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Dec 10, 2024Summit Research PeptidesUnapproved New Drugs/MisbrandedSemaglutide, Tirzepatide, Retatrutide, Cagrilintide, MazdutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 12, 2024Nomida.bizUnapproved New Drugs/MisbrandedSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 7, 2024US Chem LabsCGMP/Finished Pharmaceuticals/AdulteratedSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 7, 2024Synthetix Inc. DBA Helix Chemical SupplyUnapproved New Drugs/MisbrandedSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Oct 2, 2023www.gorillahealing.comFinished Pharmaceuticals/Unapproved New Drug/MisbrandedSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov

A warning letter states FDA’s view when it was issued; it is not a court finding, and the company may have responded since. The later-letters column repeats what FDA’s warning letter index lists for each letter.

Recalls naming tirzepatide

Record
Sep 25, 2026Houston Rx LLCTirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.Lack of assurance of sterility.Class IIOngoingD-0040-2027
Sep 24, 2026Apothecary Pharma LLCTirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC 27513, NDC 85091-001-18.Lack of Assurance of SterilityClass IIOngoingD-0036-2027
Sep 10, 2026Carolina Infusion, LLCTIRZEPATIDE/CYANOCOBALAMIN 26/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0027-2027
Sep 10, 2026Carolina Infusion, LLCTIRZEPATIDE/CYANOCOBALAMIN 85/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0030-2027
Sep 10, 2026Carolina Infusion, LLCTIRZEPATIDE/CYANOCOBALAMIN 64/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0028-2027
Sep 10, 2026Carolina Infusion, LLCTIRZEPATIDE/CYANOCOBALAMIN 76/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0029-2027
Sep 10, 2026Carolina Infusion, LLCTIRZEPATIDE 26 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infus...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0017-2027
Feb 26, 2026New Life Pharma LLCTirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-04.Lack of Assurance of SterilityClass IIOngoingD-0395-2026
Feb 26, 2026New Life Pharma LLCTirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-03.Lack of Assurance of SterilityClass IIOngoingD-0394-2026
Oct 15, 2025ProRx LLCTirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139...Lack of Assurance of SterilityClass IIOngoingD-0120-2026
Jul 30, 2025GenoGenix LLCTirzepatide, 60mg/10 mL for Injection, 10mL vial lyophilized, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labe...Lack of Assurance of SterilityClass IIOngoingD-0092-2026
Jul 18, 2025AEQUITA PHARMACYTirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do n...Lack of Processing Controls.Class IIOngoingD-0555-2025
Jul 18, 2025AEQUITA PHARMACYTirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2mL Multi Dose Vial, Refrigerate, Do no...Lack of Processing Controls.Class IIOngoingD-0554-2025
Jul 18, 2025AEQUITA PHARMACYTirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, D...Lack of Processing Controls.Class IIOngoingD-0558-2025
Jul 18, 2025AEQUITA PHARMACYTirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 3 x 2 mL Multi Dose Vial, Refrigerate...Lack of Processing Controls.Class IIOngoingD-0560-2025
Jul 18, 2025AEQUITA PHARMACYTirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do ...Lack of Processing Controls.Class IIOngoingD-0556-2025
Jul 18, 2025AEQUITA PHARMACYTirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do ...Lack of Processing Controls.Class IIOngoingD-0557-2025
Jul 18, 2025AEQUITA PHARMACYTirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do ...Lack of Processing Controls.Class IIOngoingD-0559-2025
May 21, 2025Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)Tirzepatide Injections, 30mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112Lack of Assurance of SterilityClass IIOngoingD-0484-2025
May 21, 2025Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)Tirzepatide/Cyanocobalamin Injectable, 15mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112Lack of Assurance of SterilityClass IIOngoingD-0485-2025
May 21, 2025Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)Tirzepatide Injections, 10mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112Lack of Assurance of SterilityClass IIOngoingD-0482-2025
May 21, 2025Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)Tirzepatide/Cyanocobalamin Injectable, 30mg/1mg/mL (15mg/0.5mg/0.5mL), pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewo...Lack of Assurance of SterilityClass IIOngoingD-0486-2025
May 21, 2025Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)Tirzepatide Injections, 20mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112Lack of Assurance of SterilityClass IIOngoingD-0483-2025
Aug 22, 2024ProRx LLCTirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01Lack of Assurance of SterilityClass IIOngoingD-0651-2024
Aug 22, 2024ProRx LLCTIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only, 3mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-02Lack of Assurance of SterilityClass IIOngoingD-0656-2024
Aug 22, 2024ProRx LLCTIRZEPATIDE 20 mg/2mL (10/mg/mL), Rx Only, 2mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-01Lack of Assurance of SterilityClass IIOngoingD-0655-2024
Apr 20, 2024Revive Rx LLC dba Revive Rx PharmacyTirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77...Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionateClass IOngoingD-0511-2024
May 11, 2023Revive Rx LLC dba Revive Rx PharmacyTirzepatide 10 mg/0.5 mL Sterile Solution-2 mL Vial, Rx Only, For Sub-Q Use Only, Compounded Drug Product By: Revive Rx, 3831 Golf Dr A, Houston, TX 77018, N...Sub-potent DrugClass IIOngoingD-0771-2023

This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.